• 1. Quinaldine red as a fluorescent light-up probe for i-motif structures
  Guimei Jiang,Lijun Xu,Kewei Wang,Xing Chen,Jine Wang,Weiguo Cao,Renjun Pei Anal. Methods 2017 9 1585
• 2. Terminal protection G-quadruplex-based turn-on fluorescence biosensor for H5N1 antibody
  Qihong Cai,Chunmei Wang,Jin Zhou,Fang Luo,Zhenyu Lin,Longhua Guo,Bin Qiu,Guonan Chen Anal. Methods 2012 4 3425
• 3. Data-driven discovery of cardiolipin-selective small molecules by computational active learning
  Bernadette Mohr,Kirill Shmilovich,Isabel S. Kleinw?chter,Dirk Schneider,Andrew L. Ferguson,Tristan Bereau Chem. Sci. 2022 13 4498
• 4. Sensitive fluorescence biosensor for folate receptor based on terminal protection of small-molecule-linked DNA
  Xiaofeng Wei,Wenlie Lin,Na Ma,Fang Luo,Zhenyu Lin,Longhua Guo,Bin Qiu,Guonan Chen Chem. Commun. 2012 48 6184
• 5. pH-Sensing fluorescence oligonucleotide probes based on an i-motif scaffold: a review
  Anna Dembska,Patrycja Bielecka,Bernard Juskowiak Anal. Methods 2017 9 6092

Quinaldine Red: Chemical Profile and Emerging Applications in Biomedical Research

Quinaldine Red, a compound with the chemical identifier CAS no. 117-92-0, is a heterocyclic organic dye that has garnered significant attention in the field of chemobiology and pharmaceutical research. This vibrant red pigment, characterized by its molecular formula C₉H₆N₂O, belongs to the quinaldine class of compounds, which are known for their diverse pharmacological properties. The unique structural features of Quinaldine Red, including its nitrogen-containing heterocycle and hydroxyl functional group, contribute to its remarkable solubility in polar solvents and its ability to interact with biological macromolecules.

The synthesis of Quinaldine Red typically involves a series of condensation and oxidation reactions, which highlight its versatility as a chemical intermediate. Recent advancements in synthetic methodologies have enabled the production of this compound with higher purity and yield, making it more accessible for research applications. The compound's stability under various environmental conditions, including light and temperature, further enhances its utility in both laboratory and industrial settings.

In the realm of biomedical research, Quinaldine Red has been explored for its potential applications in drug development and diagnostic imaging. Its ability to bind to specific biomolecules has led to investigations into its role as a fluorescent probe for cellular studies. Researchers have leveraged its photophysical properties to develop novel techniques for visualizing biological processes at the molecular level. For instance, Quinaldine Red has been utilized in flow cytometry to track the dynamics of protein-protein interactions within living cells, providing valuable insights into cellular signaling pathways.

Moreover, the compound's interaction with nucleic acids has sparked interest in its potential as an antiviral or anticancer agent. Studies have demonstrated that Quinaldine Red can disrupt viral replication by interfering with nucleic acid synthesis, making it a promising candidate for therapeutic intervention. Additionally, its ability to induce apoptosis in cancer cells has been observed in preclinical trials, suggesting its potential as a component in combinatorial cancer therapies.

The use of Quinaldine Red in diagnostic imaging has also seen significant progress. Its high affinity for certain metal ions allows it to be used as a contrast agent in magnetic resonance imaging (MRI), improving the resolution of anatomical structures. This application has particular relevance in neuroimaging, where Quinaldine Red has been employed to visualize neural networks and assess brain activity. The compound's ability to emit light upon excitation also makes it suitable for fluorescence microscopy techniques, enabling researchers to study dynamic processes such as neurotransmitter release and synaptic plasticity.

Recent research has further expanded the applications of Quinaldine Red into the field of nanotechnology. By incorporating this dye into functionalized nanoparticles, scientists have developed innovative drug delivery systems capable of targeting specific tissues or cells. These nanocarriers, loaded with Quinaldine Red-based payloads, have shown enhanced bioavailability and reduced toxicity compared to conventional formulations. This innovation holds promise for treating a wide range of diseases, including those that are currently challenging to address with existing therapies.

The environmental impact of Quinaldine Red is another area of growing interest. Studies have assessed its biodegradability and ecotoxicity profile under various conditions, ensuring that its use does not pose significant risks to ecosystems. Efforts are ongoing to develop more sustainable synthetic routes that minimize waste generation and energy consumption. These initiatives align with global efforts to promote green chemistry principles and reduce the environmental footprint of chemical manufacturing processes.

As the field of chemobiology continues to evolve, Quinaldine Red remains at the forefront of innovation due to its multifaceted properties and broad applicability. Ongoing research efforts aim to uncover new therapeutic potentials and refine existing applications through interdisciplinary collaborations between chemists, biologists, and medical researchers. The continued exploration of this compound underscores its importance as a cornerstone molecule in modern biomedical science.

• 71068-06-9(Pyridinium, 1,1'-(1,4-butanediyl)bis[2-[2-[4-(dimethylamino)phenyl]ethenyl]-, dibromide (9CI))
• 23617-53-0(Quinolinium,1-ethyl-6-[(1-ethylpyridinium-4-yl)amino]-2-[2-[4-[(1-ethylpyridinium-4-yl)amino]phenyl]ethenyl]-,iodide (1:3))
• 3915-61-5(1-Methyl-2-p-dimethylamino-styryl-quinoliniumiodide)
• 76529-17-4(Quinolinium, 1-ethyl-2-[2-(methylphenylamino)ethenyl]-, iodide)
• 84195-77-7(Pyridinium,2,4-bis[2-[4-(dimethylamino)phenyl]ethenyl]-1-ethyl-, iodide (1:1))
• 3785-01-1(Pyridinium,2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-ethyl-, iodide (1:1))
• 57439-27-7(Pyridinium,2-[2-[4-(diethylamino)phenyl]ethenyl]-1-ethyl-, iodide (1:1))
• 181885-68-7(LDS-751)
• 53724-80-4(Quinolinium, 1-ethyl-2-[2-(phenylamino)ethenyl]-, iodide)
• 89846-26-4(Quinolinium, 2-[4-[4-(dimethylamino)phenyl]-1,3-butadien-1-yl]-1-ethyl-, perchlorate (1:1))